Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 26 | 2025 | 1038 | 4.330 |
Why?
|
| Endovascular Procedures | 11 | 2025 | 309 | 3.400 |
Why?
|
| Brain Ischemia | 13 | 2023 | 405 | 3.380 |
Why?
|
| Thrombectomy | 12 | 2025 | 197 | 2.350 |
Why?
|
| Stents | 9 | 2025 | 415 | 2.040 |
Why?
|
| Thrombolytic Therapy | 8 | 2024 | 252 | 1.880 |
Why?
|
| Intracranial Arteriosclerosis | 3 | 2025 | 63 | 1.870 |
Why?
|
| Embolization, Therapeutic | 4 | 2025 | 261 | 1.770 |
Why?
|
| Fibrinolytic Agents | 8 | 2024 | 233 | 1.120 |
Why?
|
| Intracranial Aneurysm | 2 | 2025 | 197 | 1.030 |
Why?
|
| Carotid Arteries | 3 | 2024 | 134 | 0.890 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 237 | 0.860 |
Why?
|
| Anticholesteremic Agents | 1 | 2025 | 148 | 0.860 |
Why?
|
| Cerebral Angiography | 3 | 2025 | 211 | 0.860 |
Why?
|
| Treatment Outcome | 18 | 2025 | 8727 | 0.720 |
Why?
|
| Triage | 1 | 2021 | 125 | 0.680 |
Why?
|
| Carotid Stenosis | 5 | 2025 | 116 | 0.590 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 248 | 0.590 |
Why?
|
| Carotid Artery, Internal, Dissection | 3 | 2025 | 31 | 0.510 |
Why?
|
| Humans | 45 | 2025 | 92303 | 0.500 |
Why?
|
| Intracranial Thrombosis | 3 | 2022 | 30 | 0.480 |
Why?
|
| Retrospective Studies | 16 | 2025 | 9679 | 0.470 |
Why?
|
| Headache Disorders, Primary | 1 | 2014 | 3 | 0.460 |
Why?
|
| Milrinone | 1 | 2014 | 7 | 0.460 |
Why?
|
| Nicardipine | 1 | 2014 | 7 | 0.460 |
Why?
|
| Vertebral Artery Dissection | 2 | 2025 | 20 | 0.460 |
Why?
|
| Vasospasm, Intracranial | 1 | 2014 | 35 | 0.450 |
Why?
|
| Vasoconstriction | 1 | 2014 | 92 | 0.450 |
Why?
|
| Mechanical Thrombolysis | 1 | 2014 | 17 | 0.440 |
Why?
|
| Vasodilator Agents | 1 | 2014 | 146 | 0.440 |
Why?
|
| Aged | 16 | 2025 | 19952 | 0.430 |
Why?
|
| Male | 23 | 2025 | 43924 | 0.430 |
Why?
|
| Catheters | 2 | 2024 | 86 | 0.430 |
Why?
|
| Middle Aged | 18 | 2025 | 27043 | 0.420 |
Why?
|
| Platelet Aggregation Inhibitors | 5 | 2025 | 159 | 0.420 |
Why?
|
| Computed Tomography Angiography | 2 | 2025 | 156 | 0.410 |
Why?
|
| Female | 23 | 2025 | 47894 | 0.400 |
Why?
|
| Venous Thrombosis | 3 | 2022 | 253 | 0.400 |
Why?
|
| Heroin Dependence | 1 | 2011 | 15 | 0.370 |
Why?
|
| Leukoencephalopathies | 1 | 2011 | 14 | 0.370 |
Why?
|
| Heroin | 1 | 2011 | 12 | 0.370 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2011 | 62 | 0.350 |
Why?
|
| Adult | 12 | 2025 | 27535 | 0.340 |
Why?
|
| Neurosurgical Procedures | 3 | 2024 | 312 | 0.310 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 6916 | 0.310 |
Why?
|
| Intracranial Hemorrhages | 3 | 2024 | 130 | 0.290 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 886 | 0.290 |
Why?
|
| Secondary Prevention | 2 | 2025 | 172 | 0.270 |
Why?
|
| Angioplasty | 4 | 2013 | 71 | 0.250 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2024 | 174 | 0.240 |
Why?
|
| Proprotein Convertase 9 | 1 | 2025 | 26 | 0.240 |
Why?
|
| Anticoagulants | 3 | 2025 | 444 | 0.240 |
Why?
|
| Carotid Artery, Internal | 1 | 2025 | 70 | 0.230 |
Why?
|
| Radial Artery | 1 | 2024 | 36 | 0.220 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 402 | 0.210 |
Why?
|
| Angiofibroma | 1 | 2023 | 4 | 0.210 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 871 | 0.200 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 47 | 0.200 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2023 | 111 | 0.200 |
Why?
|
| Dabigatran | 1 | 2022 | 25 | 0.190 |
Why?
|
| Hospital Mortality | 1 | 2024 | 444 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 2 | 2013 | 143 | 0.190 |
Why?
|
| Reimbursement, Incentive | 1 | 2021 | 38 | 0.180 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 30 | 0.180 |
Why?
|
| Transportation of Patients | 1 | 2021 | 35 | 0.180 |
Why?
|
| Head Injuries, Penetrating | 1 | 2022 | 65 | 0.180 |
Why?
|
| Warfarin | 1 | 2022 | 105 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 490 | 0.180 |
Why?
|
| Health Expenditures | 1 | 2021 | 97 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 105 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 164 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2021 | 248 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 377 | 0.150 |
Why?
|
| Brain | 2 | 2024 | 2354 | 0.150 |
Why?
|
| Cerebral Infarction | 2 | 2024 | 73 | 0.150 |
Why?
|
| Young Adult | 4 | 2015 | 6628 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 2 | 2012 | 360 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3513 | 0.140 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 380 | 0.140 |
Why?
|
| Maxillary Artery | 1 | 2017 | 3 | 0.140 |
Why?
|
| Ankylosis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Enbucrilate | 1 | 2017 | 8 | 0.140 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2017 | 21 | 0.130 |
Why?
|
| Chicago | 1 | 2021 | 1466 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2683 | 0.130 |
Why?
|
| Risk Factors | 7 | 2025 | 5705 | 0.120 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2014 | 39 | 0.110 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 11 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2017 | 405 | 0.110 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2012 | 18 | 0.100 |
Why?
|
| Early Medical Intervention | 1 | 2012 | 20 | 0.100 |
Why?
|
| Cerebral Veins | 1 | 2012 | 30 | 0.100 |
Why?
|
| Cerebral Revascularization | 1 | 2012 | 27 | 0.100 |
Why?
|
| Hypolipidemic Agents | 1 | 2012 | 99 | 0.090 |
Why?
|
| Dysarthria | 1 | 2011 | 6 | 0.090 |
Why?
|
| Smoke | 1 | 2011 | 27 | 0.090 |
Why?
|
| Nystagmus, Pathologic | 1 | 2011 | 35 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 121 | 0.090 |
Why?
|
| Inpatients | 2 | 2023 | 331 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2012 | 59 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 193 | 0.090 |
Why?
|
| Heparin | 1 | 2012 | 185 | 0.090 |
Why?
|
| Hemorrhage | 2 | 2024 | 291 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2012 | 909 | 0.090 |
Why?
|
| Hematoma | 1 | 2011 | 107 | 0.090 |
Why?
|
| Adolescent | 1 | 2023 | 9491 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1594 | 0.080 |
Why?
|
| Cerebellum | 1 | 2011 | 251 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2024 | 4469 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 261 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1073 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2014 | 2976 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 1398 | 0.060 |
Why?
|
| Medical Audit | 1 | 2006 | 39 | 0.060 |
Why?
|
| Computers | 1 | 2006 | 111 | 0.060 |
Why?
|
| Texas | 1 | 2006 | 126 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 311 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2024 | 59 | 0.060 |
Why?
|
| Equipment Design | 1 | 2025 | 420 | 0.050 |
Why?
|
| Basilar Artery | 1 | 2023 | 40 | 0.050 |
Why?
|
| Device Removal | 1 | 2024 | 163 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2024 | 219 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 179 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2022 | 10 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 2 | 2012 | 33 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2012 | 238 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 2 | 2013 | 186 | 0.050 |
Why?
|
| Recurrence | 1 | 2025 | 1180 | 0.050 |
Why?
|
| Reimbursement Mechanisms | 1 | 2021 | 41 | 0.050 |
Why?
|
| Resuscitation | 1 | 2022 | 111 | 0.050 |
Why?
|
| Cost Savings | 1 | 2021 | 72 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 390 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2022 | 672 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2006 | 2369 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 440 | 0.040 |
Why?
|
| Algorithms | 1 | 2006 | 1960 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 1150 | 0.030 |
Why?
|
| Child | 2 | 2022 | 7303 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 926 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 3112 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 3773 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 28 | 0.030 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 29 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 5430 | 0.030 |
Why?
|
| Early Ambulation | 1 | 2013 | 30 | 0.030 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 74 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2013 | 128 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 295 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 115 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 416 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 278 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 707 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 856 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 652 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2012 | 262 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 456 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7346 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1764 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1504 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 28045 | 0.010 |
Why?
|